GSK plc announced that Iain Mackay decided to retire from GSK. The Board has agreed that he will step down as an Executive Director of the Board in May 2023. The Board has selected Ms Julie Brown, currently Chief Operating and Financial Officer, Burberry Group plc, as successor to Iain.

Julie is a highly respected CFO with extensive experience in the biopharma and medtech sectors, having previously worked at AstraZeneca plc and Smith & Nephew plc; and as a non-executive director and Audit Chair of Roche Holding AG. Julie will join GSK in April 2023 and will work with Iain to transition responsibilities, taking responsibility as an Executive Director of GSK on 1 May 2023. Julie serves as Chief Operating and Financial Officer, Burberry Group plc and an Executive Director.

She joined Burberry from Smith & Nephew where she was the Group CFO from 2013-2017. Before this, she was Interim Group CFO of AstraZeneca, having worked at the company for 25 years in finance, commercial and strategic roles. Julie has also served as a Non-Executive Director and Audit Chair of Roche Holding AG.

She is also co-Chair of the Prince's Accounting for Sustainability Project's CFO Leadership Network, a member of the Prime Minister's Business Council, the Business Advisory Board to the Mayor of London and Patron of Oxford University Women in Business. Julie is a Fellow of the Institute of Chartered Accountancy and the Institute of Tax and qualified with KPMG International Limited.